Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,321-1,332 of 4,306
Drug study icon
WithdrawnNCT03994965

The Sub-Sero Study

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 45 Years
Countries
Sponsor
Bjorn H. Ebdrup
Condition
Schizophrenia
Drug study icon
CompletedNCT01364792

To Rescue Cognition With Valaciclovir

This summary needs review. Please check the official study record and contact the research team for details.

In Groningen
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
Netherlands
Sponsor
University Medical Center Groningen
Condition
Schizophrenia
Other study type icon
CompletedNCT06043206

Bariatric Surgery in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Barcelona
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.
Countries
Spain
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Condition
Schizophrenia
Behavioral study icon
CompletedNCT05500651

Dance and Movement Therapy in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Amasya
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioral
Countries
Türkiye
Sponsor
Amasya University
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2009-017271-17

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Bulgaria
Sponsor
Janssen-Cilag International NV
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2006-005734-20

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Flexible Dose Paliperidone ER in the Treatment of Subjects with Schizoaffective Disorder

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Bulgaria
Sponsor
Janssen L.P.
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2006-003475-13

A SIXTEEN-WEEK, MULTI-CENTER, OPEN-LABEL STUDY EVALUATING THE SAFETY, TOLERABILITY, AND EFFICACY OF SWITCHING FROM QUETIAPINE TO ZIPRASIDONE IN SUBJECTS DIAGNOSED WITH SCHIZOPHRENIA OR SCHIZOAFFECT...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Germany, Greece
Sponsor
Pfizer Pharma GmbH
Condition
Schizophrenia
Drug study icon
TerminatedEUCTR 2006-003519-33

RAPID - An Open-Label, Randomised, Multicentre Phase IIIb Study to Evaluate the Efficacy and Tolerability of Quetiapine IR (Immedicate Release), over 14 days, in Acute Schizophrenia / Schizoaffecti...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
United Kingdom
Sponsor
AstraZeneca UK Limited
Condition
Schizophrenia
Drug study icon
TerminatedEUCTR 2013-000834-36

Simvastatin addition to improve symptoms, cognition and metabolic syndrome in patients with recent-onset schizophrenia.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Netherlands
Sponsor
University Medical Center Utrecht
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.